P. Barnardt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
P. Barnardt has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
L Fourie
Department of Medical Imaging and Clinical Oncology, Tygerberg Hospital, Parow
1 shared publication- Stephanie Griffith-Richards
Stellenbosch University
1 shared publication
Latest Publications
- 1 July 2021
- Published by Elsevier in Best Practice & Research Clinical Obstetrics & Gynaecology
- Vol. 74, 149-158
People living with human immunodeficiency virus and gestational trophoblastic neoplasm
- 1 July 2021
- Published by Elsevier in Best Practice & Research Clinical Obstetrics & Gynaecology
- Vol. 74, 149-158
People living with human immunodeficiency virus and gestational trophoblastic neoplasm
- Open Access
- 3 July 2018
- Published by Taylor & Francis in Southern African Journal of Gynaecological Oncology
- Vol. 10 (2) , 30-33
Ovarian germ cell tumour and bleomycin-induced lung injury
Bleomycin, an antibiotic agent with antitumour activity, is an important drug in the management of many oncological malignancies such as lymphoma and germ cell tumours. These tumours are potentially curable and mostly affect young people. The potential side effects and long-term toxicities should be considered. The major limitation of bleomycin therapy is pulmonary toxicity and may be life threatening in about 10% of cases. This article reports a case of an ovarian mixed germ cell tumour, which presented with bleomycin-associated pulmonary toxicity.
- 3 July 2018
- Published by Taylor & Francis in Southern African Journal of Gynaecological Oncology
- Vol. 10 (2) , 30-33
Open AccessOvarian germ cell tumour and bleomycin-induced lung injury
Bleomycin, an antibiotic agent with antitumour activity, is an important drug in the management of many oncological malignancies such as lymphoma and germ cell tumours. These tumours are potentially curable and mostly affect young people. The potential side effects and long-term toxicities should be considered. The major limitation of bleomycin therapy is pulmonary toxicity and may be life threatening in about 10% of cases. This article reports a case of an ovarian mixed germ cell tumour, which presented with bleomycin-associated pulmonary toxicity.
- Open Access
- 1 January 2011
- Published by Taylor & Francis in Southern African Journal of Gynaecological Oncology
- Vol. 3 (2) , 76-78
A metastatic unclassified trophoblastic tumour with spontaneous bilateral pneumothoraces
Gestational trophoblastic disease (GTD) is a spectrum of diseases associated with pregnancy. Epithelioid trophoblastic tumour (ETT) is a rare neoplastic proliferation of the intermediate trophoblast that can be distinguished from choriocarcinoma. A 35-year-old female presented with persistent vaginal bleeding, raised beta human chorionic gondaotrophin (β-HCG) (13 175 IU/l) and, on ultrasound, what appeared to be a molar pregnancy. Microscopy and immunohistochemistry confirmed the diagnosis of ETT. Computed tomography (CT) scan confirmed bilateral small lung and liver metastases, and vaginal sonar, a single metastasis next to the urethra. Combination etoposide and cisplatin chemotherapy was completed. Restaging lung CT detected numerous cystic lesions and bilateral spontaneous pneumothoraces, caused by the rupture of subpleural cystic lesions. After second-line methotrexate-based chemotherapy, the patient was admitted to hospital with shortness of breath. Bilateral underwater drains were inserted to address the complication of persistent spontaneous bilateral pneumothoraces, but she passed away. ETT is a rare malignant disorder associated with pregnancy. No standard treatment guidelines exist, and these patients need the efforts of a multidisciplinary team with experience in oncology
- 1 January 2011
- Published by Taylor & Francis in Southern African Journal of Gynaecological Oncology
- Vol. 3 (2) , 76-78
Open AccessA metastatic unclassified trophoblastic tumour with spontaneous bilateral pneumothoraces
Gestational trophoblastic disease (GTD) is a spectrum of diseases associated with pregnancy. Epithelioid trophoblastic tumour (ETT) is a rare neoplastic proliferation of the intermediate trophoblast that can be distinguished from choriocarcinoma. A 35-year-old female presented with persistent vaginal bleeding, raised beta human chorionic gondaotrophin (β-HCG) (13 175 IU/l) and, on ultrasound, what appeared to be a molar pregnancy. Microscopy and immunohistochemistry confirmed the diagnosis of ETT. Computed tomography (CT) scan confirmed bilateral small lung and liver metastases, and vaginal sonar, a single metastasis next to the urethra. Combination etoposide and cisplatin chemotherapy was completed. Restaging lung CT detected numerous cystic lesions and bilateral spontaneous pneumothoraces, caused by the rupture of subpleural cystic lesions. After second-line methotrexate-based chemotherapy, the patient was admitted to hospital with shortness of breath. Bilateral underwater drains were inserted to address the complication of persistent spontaneous bilateral pneumothoraces, but she passed away. ETT is a rare malignant disorder associated with pregnancy. No standard treatment guidelines exist, and these patients need the efforts of a multidisciplinary team with experience in oncology